嘉和生物(06998) - 最新股东
*注解：（Ｌ）- 好仓, （Ｓ）- 淡仓, （Ｐ）- 可供借出的股份。
全部董事非董事
| 股东名称 | 持有权益的股份数目 | 占已发行的有投票权股份百分比 | 占股本比例 | 最后申报有关通知之日期 | 表格序号 |
|---|---|---|---|---|---|
| 倪昕 | 43.77% | 2024-10-04 | IS20241009E00373 | ||
| 倪昕 (董事) | 37.69% | 2025-12-30 | DA20260105E00581 | ||
| OrbiMed Advisors LLC | 10.77% | 2025-12-30 | CS20260108E00049 | ||
| 沈南鵬 | 9.28% | 2024-09-13 | IS20241010E00565 | ||
| DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH | 7.63% | 2024-10-07 | CS20241021E00533 | ||
| FORBRIGHT GLOBAL LIMITED | 7.63% | 2024-10-07 | CS20241021E00534 | ||
| 李浩良 | 6.76% | 2025-12-30 | IS20260105E00231 | ||
| Hillhouse Investment Management, Ltd. | 6.36% | 2025-12-30 | CS20260105E00672 | ||
| Hillhouse Fund IV, L.P. | 6.28% | 2025-12-30 | CS20260105E00673 | ||
| 云南沃森生物技术股份有限公司 | 1.87% | 2020-10-28 | CS20210204E00004 | ||
| Temasek Holdings (Private) Limited | 1.55% | 2024-09-11 | CS20240916E00115 | ||
| Temasek Capital (Private) Limited | 1.45% | 2020-11-02 | CS20201103E00327 | ||
| 郭峰 (董事) | 1.05% | 2025-09-03 | DA20250905E00116 | ||
| 翟婧 (董事) | 0.16% | 2025-12-30 | DA20260105E00592 | ||
| 翁承毅 (董事) | 0.08% | 2024-11-20 | DA20241218E00135 |